Traduction de «Système de suivi de la qualité de vie » (Français → Anglais) :

19. Calls on the Commission to develop standards to ensure general harmonisation and coherence in the regulation of parking and vehicle access to urban areas, the categorisation of vehicles, the different classes of emissions, road signs, disability-friendly transport systems and technical standards in intelligent transport systems, and to boost the impetus for pedestrian zones and the protection of historical areas and generally improve the environment and public mobility; points out that the keystone of the SUMPs is quality of life, ...[+++]a corollary of which is the emphasis on freeing cities from traffic congestion and planning parking facilities to ensure freedom of movement for pedestrians and the attractiveness of city centres; asks the Commission to support coordinated and integrated strategic public transport solutions to relieve transport networks, urban highways and access roads to workplaces in order to improve people’s quality of life and to encourage a better work-life balance, while increasing productivity; also calls on the authorities to increase the use of intelligent technologies that can help solve problems related to urban mobility, such as on-board satellite sensors in vehicles and smart ticketing;

Those quality schemes should be subject to a monitoring system of official controls, in line with the principles set out in Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules , and should include a system of checks at all stages of production, processing and distribution.

- Foster the emergence of innovative ICT-based products, services and systems for ageing well at home, in the community, and at work, thus increasing the quality of life, autonomy, participation in social and economic life, skills and employability of older people and ensuring that health and social care is economically viable, whilst increasing the provision of such care in everyday life.

31. Welcomes the prospect of a Green Paper on demographic trends in the EU, to be followed by concrete actions, which should, in a coherent whole, offer concrete guidelines for meeting the manifold challenges linked to an ageing population; looks forward to its suggesting ways of providing the highest possible quality of life for the elderly, whilst at the same time ensuring sustainable pensions and health systems, taking account of the costs of long-term health care; underlines the necessit ...[+++]y of giving special attention to research on, and remedies for, age-related health issues (such as neurodegenerative diseases, arthritis and mobility problems);

31. Welcomes the prospect of a Green Paper on demographic trends in the EU, to be followed by concrete actions, which should, in a coherent whole, offer concrete guidelines for meeting the manifold challenges linked to an ageing population; looks forward to its suggesting ways of providing the highest possible quality of life for the elderly, whilst at the same time ensuring sustainable pensions and health systems, taking account of the costs of long-term health care; underlines the necessit ...[+++]y of giving special attention to research on, and remedies for, age-related health issues (such as neurodegenerative diseases, arthritis and mobility problems);

28. Welcomes the prospect of a Green Paper on demographic trends in the EU, to be followed by concrete actions, which should, in a coherent whole, offer concrete guidelines for meeting the manifold challenges linked to an ageing population; looks forward to its suggesting ways of providing the highest possible quality of life for the elderly, whilst at the same time ensuring sustainable pensions and health systems, taking account of the costs of long-term health care; underlines the necessit ...[+++]y of giving special attention to research on, and remedies for, age-related health issues (such as neurodegenerative diseases, arthritis and mobility problems);